This kit provides quantitative measurement of soluble AGER (sRAGE) in mouse samples, supporting immunology research into receptor for advanced glycation end-products signaling. Because sRAGE functions as a decoy receptor whose circulating levels shift markedly between baseline and inflammatory states, accurate quantification across both conditions demands a carefully calibrated assay.
Detection Range: The 31.25–2000 pg/mL range spans reported mouse serum sRAGE concentrations under both homeostatic and inflammatory conditions. Samples from acute injury or diabetic models, where sRAGE can rise substantially, may require dilution, while baseline measurements typically fall within range without concentration steps.
Sensitivity: At 7.81 pg/mL, the kit detects sRAGE in low-abundance samples such as conditioned media from unstimulated macrophages or endothelial cells, where shed and secreted sRAGE isoforms are present at minimal levels prior to inflammatory activation.
Sample Compatibility: Validation across serum, plasma, cell culture supernates, and tissue homogenates enables researchers to correlate circulating sRAGE with local tissue expression — for example, comparing plasma levels to lung homogenate concentrations in models of acute lung injury or pulmonary fibrosis.
Assay Efficiency: Requiring only 50–100 µL and 1–5 hours, the protocol accommodates limited-volume mouse bleeds and same-day analysis of time-course experiments involving serial sampling.
This kit is directly applicable to studies of diabetic complications, sepsis-driven inflammation, and Alzheimer's disease neuroinflammation models.